This study elucidates multiple steps of the pathogenesis of EAE pathology within the brain independent of the spinal cord and shows microglia within the brain are not direct responders of IFNs, but express transcripts associated with synaptic pruning, potentially contributing to pathological remodeling of neuronal circuits.
Abstract
Neuronal pathology plays a prominent role in the cognitive and neuropathic symptoms of multiple sclerosis; however, little is known about these pathological signals to neurons in the brain and their consequences on cognition. Here, using a transgenic reporter of IFN signaling with spatial RNA-sequencing, we determined myelin-specific autoimmune T cells enter the brain parenchyma through the interface between the fimbria and third ventricle. Here, astrocytes and microglia express high levels of MHC-II-associated transcripts. Using this reporter, we also showed microglia within the brain are not direct responders of IFNs, but express transcripts associated with synaptic pruning, potentially contributing to pathological remodeling of neuronal circuits. Moreover, both type-I and type-II IFNs are required for T cells to infiltrate the brain and initiate an IFN response associated with synaptic and metabolic programs in neurons and astrocytes in the cortex and hippocampus. In summary, this study elucidates multiple steps of the pathogenesis of EAE pathology within the brain independent of the spinal cord. IFNs activate astrocytes and neurons in EAE brain Summary Autoreactive T cells in EAE activate IFN-responsive pathways in neurons and astrocytes in the brain. T cells enter the brain through the fimbria and drive transcriptional signatures of synaptic dysfunction in neurons and synaptic pruning in microglia.
This review summarizes how astrocytes contribute to neuroinflammatory processes in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, central nervous system injury, infection, multiple sclerosis, epilepsy, and autism spectrum disorder.
Shi-Jun Peng, Le-Peng Wang, J. Ouyang et al.· MedComm· 0 citations
GFAP is an efficient biomarker in CSF, plasma, and saliva, which is associated with amyloid pathology, cognitive impairment, and AD, and can be used to extract significant information about AD mechanisms and find opportunities to identify diagnosis, prognosis and therapy.
Riddhi Upadhyay, T. Srinivasan, R. Umapriya et al.· International review of neur...· 0 citations
It is shown that loss of microglial PS1 shifts microglia toward a transcriptional and signaling state that enhances NMDA receptor-dependent synaptic activity and improves memory, demonstrating that microglial molecular programs can directly modulate neuronal excitability.
Paula da Silva Frost, C. Martínez, Alon Millet et al.· Journal of Neuroscience· 0 citations
There was no evidence of astrogliosis after microglia ablation as determined by proteome analysis and brain histology, crucial for interpreting changes to the CSF proteome in relation to neuroinflammatory changes in neurological diseases.
S. Büchner, Si-Hui Song, Stephan A. Müller et al.· Proteomics· 0 citations
Microglia typically exist in a resting state of a mature brain and monitors the brain environment. In response to brain injuries or immunological stimuli, however, microglia are readily activated. In their activated state, they can serve diverse beneficial functions essential for enhancing neuron survival through the r...